Skip to content

A study on the utilization and impact of blended learning in cardiac rehabilitation based on Learning-pass

A study on the utilization and impact of blended learning in cardiac rehabilitation based on Learning-pass

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093694
Enrollment
Unknown
Registered
2024-12-10
Start date
2024-12-10
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Experimental group:The experimental group received pre-discharge cardiac rehabilitation education by conventional means, and after discharge received the education and supervision information distribu
Control group:The control group received cardiac rehabilitation education before discharge by conventional means, and received education and supervision information issued by the research group in the

Sponsors

Affiliated Hospital of Hebei University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for coronary heart disease established by the International Society of Cardiology and Association/World Health Organization in 1979; 2. Soon to be discharged from hospital, live in the city; 3. Normal cognitive, reading, writing and understanding abilities; 4. Owning and using a smartphone; 5. Good mental condition, able to communicate orally and in writing; 6. Be able to move freely; 7. Informed consent.

Exclusion criteria

Exclusion criteria: There are contraindications to exercise rehabilitation, Examples include unstable angina pectoris, acute myocardial infarction, uncontrolled arrhythmias, decompensated heart failure, complex ventricular arrhythmias, severe pulmonary hypertension, intracavitary thrombosis, recent thrombophlebitis with or without pulmonary embolism, severe obstructive cardiomyopathy, severe or symptomatic aortic stenosis, high blood pressure > 220mmHg, uncontrolled Patients with inflammatory or infectious diseases, any muscle-skeletal muscle diseases that hinder exercise training, complicated with severe liver and kidney function impairment, severe gastrointestinal diseases, malignant tumors, etc.

Design outcomes

Primary

MeasureTime frame
Coronary heart disease self-management Behavior Scale;Medication compliance scale;Generalized Anxiety Disorder Scale (GAD-7);Patient Health Depression Scale (PHQ-9);Physical fitness test;Physiological and biochemical indicators;

Secondary

MeasureTime frame
Feasibility study;

Countries

China

Contacts

Public ContactCui Shanshan

Affiliated Hospital of Hebei University

18031202512@163.com+86 180 3120 2512

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026